As a precision medicine clinical research organization, we have brought together new technologies, expertise and operational scale to help the life sciences improve the speed, cost and success rate of bringing life-changing therapies to patients.
Precision Convergence, the combined power of trials, labs and data sciences to drive faster clinical development
What sets us apart is the way we integrate clinical trial execution with deep scientific knowledge, laboratory expertise, and advanced data sciences. This is Precision Convergence: maximizing insights into patient biology and accelerating the pace of scientific discovery and approval.
“Targeted medicine is the way forward.”
Gyöngyi Hatvani
Senior CPM, Budapest
“Targeted medicine is the way forward.”
Gyöngyi Hatvani
Senior CPM, Budapest
Our reputation is built on success in these areas
Oncology & Immuno-Oncology
Through 20+ years running successful oncology trials, we’ve developed a unique blend of proprietary technologies, flexible processes, and creative problem-solving abilities that advance even the most challenging clinical development programs.
Rare & Orphan Disease
With experience built on 150+ orphan disease projects covering 80+ rare diseases, we know how to anticipate logistical and regulatory obstacles and craft bold solutions that drive rare disease development programs.
Cell & Gene Therapy
With team members who are global thought leaders in cell and gene therapy development, Precision brings together scientific, clinical and regulatory expertise that is advancing the development of these programs as well as oncolytic viruses, cancer vaccines and radiolabeled ligands.
Our novel approach impacts many areas of human health
Neurology
We combine advances in neurology biomarkers and biomarker detection technology for robust therapeutic development.
Autoimmune & Allergy
As one of the top-rated clinical research companies, we support development programs with state-of-the-art immune monitoring solutions and immunogenicity testing expertise.
COVID-19
We are engaged in COVID-19 research with comprehensive solutions for all areas of therapeutic, vaccine and diagnostic development.
Pediatric
Advanced clinical trial design expertise and sensitive biomarker detection technologies accelerate pediatric therapeutic development.
Companion Diagnostics
Our integrated clinical development, biomarker assay, regulatory strategy and commercialization capabilities deliver unique value for CDx programs.
Decentralized Clinical Trials
We’ve built well-honed systems, processes, and relationships specific to DCTs that are ready to be applied to your trial—pandemic related or any other. The result is a full portfolio of DCT capabilities to address any challenge your trial might face.
Precision covers the globe, supporting trials at every stage
From early development to regulatory approval, from sea to sea, Precision is a global partner to many of the most innovative life-sciences companies in the world.
Trusted clinical research organization accreditations
